951 related articles for article (PubMed ID: 15313732)
21. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
23. Investment in new technology research can save future health care dollars.
Reintgen D; Albertini J; Milliotes G; Marshburn J; Cruse CW; Rapaport D; Berman C; Glass F; Fensske N; Einstein AB; Lyman G
J Fla Med Assoc; 1997 Mar; 84(3):175-81. PubMed ID: 9143169
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
26. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of elective lymph node dissection in malignant melanoma of the extremities and trunk. An analysis in view of the sentinel lymph node biopsy].
Zimmermann T; Andresen S; Schmitt H; Padberg W
Zentralbl Chir; 2001 Apr; 126(4):279-82. PubMed ID: 11370389
[TBL] [Abstract][Full Text] [Related]
28. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
29. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value.
Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K
Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
Queirolo P; Taveggia P; Gipponi M; Sertoli MR
J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
[TBL] [Abstract][Full Text] [Related]
32. [Feasibility and technical problems of sentinel node analysis in melanoma].
Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
[TBL] [Abstract][Full Text] [Related]
33. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI).
Rossi CR; De Salvo GL; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Montesco MC; Casara D; Schiavon M; Foletto M; Baldini F; Testori A
J Nucl Med; 2006 Feb; 47(2):234-41. PubMed ID: 16455628
[TBL] [Abstract][Full Text] [Related]
34. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
[TBL] [Abstract][Full Text] [Related]
35. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
[TBL] [Abstract][Full Text] [Related]
36. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T
Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276
[TBL] [Abstract][Full Text] [Related]
38. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]